These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7955659)

  • 1. Potential alloimmune factors and immunotherapy in recurrent miscarriage.
    Scott JR; Branch DW
    Clin Obstet Gynecol; 1994 Sep; 37(3):761-7. PubMed ID: 7955659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
    Am J Reprod Immunol; 1994 Sep; 32(2):55-72. PubMed ID: 7826502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of recurrent miscarriage associated with immunologic disorders: Is paternal lymphocyte immunization a relic of the past?
    Takeshita T
    J Nippon Med Sch; 2004 Oct; 71(5):308-13. PubMed ID: 15514447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of pregnancy in women with recurrent spontaneous abortion following immunotherapy with allogeneic lymphocytes.
    Agrawal S; Kishore R; Halder A; Sharma A; Sharma RK; Das V; Shukla BR; Agarwal SS
    Hum Reprod; 1995 Sep; 10(9):2280-4. PubMed ID: 8530652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloimmune neonatal neutropenia is a potential side effect of immunization with leukocytes in women with recurrent spontaneous abortions.
    Bux J; Westphal E; de Sousa F; Mueller-Eckhardt G; Mueller-Eckhardt C
    J Reprod Immunol; 1992 Oct; 22(3):299-302. PubMed ID: 1453393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
    Daya S; Gunby J
    Am J Reprod Immunol; 1994 Dec; 32(4):294-302. PubMed ID: 7718097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of immune components and their association with recurrent pregnancy loss.
    Tasadduq R; Ajmal L; Batool F; Zafar T; Babar A; Riasat A; Shakoori AR
    Hum Immunol; 2021 Mar; 82(3):162-169. PubMed ID: 33581927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limiting dilution analysis of the allo-MHC anti-paternal cytotoxic T cell response. II: Recurrent spontaneous abortion and the effect of immunotherapy.
    Manyonda IT; Pereira RS; Pearce JM; Sharrock CE
    Clin Exp Immunol; 1993 Jul; 93(1):132-7. PubMed ID: 8324899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA frequency, HLA sharing and immunotherapy in the management of recurrent miscarriage.
    Purandare AS; Smith DS; Wilson PJ
    Int J Fertil Menopausal Stud; 1993; 38(4):219-24. PubMed ID: 8401680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for recurrent pregnancy loss.
    Carp H
    Best Pract Res Clin Obstet Gynaecol; 2019 Oct; 60():77-86. PubMed ID: 31521575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes immunotherapy for preserving pregnancy: Mechanisms and Challenges.
    Hajipour H; Nejabati HR; Latifi Z; Hamdi K; Bahrami-Asl Z; Fattahi A; Nouri M
    Am J Reprod Immunol; 2018 Sep; 80(3):e12853. PubMed ID: 29603821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse influence of numbers of previous miscarriages on results of paternal lymphocyte immunization in patients with recurrent spontaneous abortions.
    Katano K; Aoki K; Ogasawara MS; Suzumori K
    Am J Reprod Immunol; 2000 Nov; 44(5):289-92. PubMed ID: 11125791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for the diagnostic and therapeutic management of recurrent alloimmune abortion.
    Cittadini E; Montemagno U; Pardi G; Perino A; Marcenò R; Semprini E; Cavallaro AM; Cignitti M; Cimino C; Colacurci N
    Acta Eur Fertil; 1991; 22(5):267-74. PubMed ID: 1845749
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy and recurrent abortion: a randomized clinical trial.
    Illeni MT; Marelli G; Parazzini F; Acaia B; Bocciolone L; Bontempelli M; Faden D; Fedele L; Maffeis A; Radici E
    Hum Reprod; 1994 Jul; 9(7):1247-9. PubMed ID: 7962426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
    Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
    Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloimmune causes of recurrent pregnancy loss.
    Porter TF; Scott JR
    Semin Reprod Med; 2000; 18(4):393-400. PubMed ID: 11355798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for recurrent miscarriage.
    Coulam CB; Clark DA
    Am J Reprod Immunol; 1994 Dec; 32(4):257-60. PubMed ID: 7718093
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
    Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
    Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of anti-paternal antibodies and leukocyte immunizations on the proportion of live births in couples with consecutive recurrent miscarriages.
    Orgad S; Loewenthal R; Gazit E; Sadetzki S; Novikov I; Carp H
    Hum Reprod; 1999 Dec; 14(12):2974-9. PubMed ID: 10601081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote pregnancy outcome after leukocyte immunotherapy.
    Kilpatrick DC; Liston WA
    Fertil Steril; 1994 Aug; 62(2):409-11. PubMed ID: 8034093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.